Cellectis ROIC
What is the ROIC of Cellectis?
The ROIC of Cellectis is -32.59%
What is the definition of ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC of companies in the Health Care sector on NASDAQ compared to Cellectis
What does Cellectis do?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Companies with roic similar to Cellectis
- Avesoro Resources has ROIC of -32.77%
- Pharmadrug has ROIC of -32.75%
- Five Prime Therapeutics Inc has ROIC of -32.73%
- Electreon Wireless Ltd has ROIC of -32.68%
- Xenetic Biosciences Inc has ROIC of -32.65%
- Miniluxe Corp has ROIC of -32.64%
- Cellectis has ROIC of -32.59%
- Sonoma Pharmaceuticals has ROIC of -32.49%
- Contact Gold has ROIC of -32.49%
- Apache has ROIC of -32.48%
- CHAR Technologies has ROIC of -32.46%
- Fangdd Network Ltd has ROIC of -32.43%
- Golden Independence Mining has ROIC of -32.42%